Crossref
NCI Will Study Drug Combinations in New Precision Treatment Initiative
JAMA · 2023
DOI: 10.1001/jama.2023.10397 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, 2023. Verfasst von Emily Harris. Hauptthemen laut MEDLINE: Precision Medicine, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Precision MedicineAntineoplastic AgentsNeoplasmsMolecular Targeted TherapyNational Cancer Institute (U.S.)United StatesDrug Therapy, CombinationClinical Studies as Topic
Substanzen
Antineoplastic Agents
Zitieren
APA
Harris, E. (2023). NCI Will Study Drug Combinations in New Precision Treatment Initiative. JAMA. https://doi.org/10.1001/jama.2023.10397
Vancouver
Harris E. NCI Will Study Drug Combinations in New Precision Treatment Initiative. JAMA. 2023. doi:10.1001/jama.2023.10397
BibTeX
@article{Harris2023,
author = {Harris, Emily},
title = {NCI Will Study Drug Combinations in New Precision Treatment Initiative},
journal = {JAMA},
year = {2023},
doi = {10.1001/jama.2023.10397}
}
EUVIMED